Gastroparesis Updates on Pathogenesis and Management

키워드

참고문헌 (84)

1. Camilleri M, "American College of Gastroenterology. Clinical guideline: management of gastroparesis", Am J Gastroenterol, 108, pp.18~37 (2013)
2. Cherian D, "Nausea and vomiting in diabetic and idiopathic gastroparesis", Neurogastroenterol Motil, 24, pp.217~222.e103 (2012)
3. Cherian D, "Abdominal pain is a frequent symptom of gastroparesis", Clin Gastroenterol Hepatol, 8, pp.676~681 (2010)
4. Jung HK, "The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006", Gastroenterology, 136, pp.1225~1233 (2009)
5. Hyett B, "Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis", Gastroenterology, 137, pp.445~452 (2009)
6. Bityutskiy LP, "Viral gastroparesis: a subgroup of idiopathic gastroparesis--clinical characteristics and long-term outcomes", Am J Gastroenterol, 92, pp.1501~1504 (1997)
7. Choung RS, "Risk of gastroparesis in subjects with type 1 and 2 diabetes in the general population", Am J Gastroenterol, 107, pp.82~88 (2012)
8. Frantzides CT, "Postoperative gastrointestinal complaints after laparoscopic Nissen fundoplication", JSLS, 10, pp.39~42 (2006)
9. Abell TL, "Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine", J Nucl Med Technol, 36, pp.44~54 (2008)
10. Kuo B, "Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects", Aliment Pharmacol Ther, 27, pp.186~196 (2008)
11. Bruno G, "13C-octanoic acid breath test to study gastric emptying time", Eur Rev Med Pharmacol Sci, 17(Suppl 2), pp.59~64 (2013)
12. Maes BD, "Combined carbon-13-glycine", carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids, 1994, pp.35, 824~831
13. Pasricha PJ, "Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying", Clin Gastroenterol Hepatol, 9, pp.567~576.e4 (2011)
14. Bashashati M, "Motility: is ‘ICC-opathy’ present in gastroparesis-like syndrome", Nat Rev Gastroenterol Hepatol, 12, pp.375~376 (2015)
15. Revicki DA, "Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index", Aliment Pharmacol Ther, 18, pp.141~150 (2003)
16. Camilleri M, "Epidemiology, mechanisms, and management of diabetic gastroparesis", Clin Gastroenterol Hepatol, 9, pp.5~12 (2011)
17. 오정환, "Recent Advances in the Pathophysiology and Treatment of Gastroparesis", Journal of Neurogastroenterology and Motility (JNM), 19(1), pp.18~24 (2013), 대한소화기 기능성질환∙운동학회
18. Angeli TR, "Loss of interstitial cells of Cajal and patterns of gastric dysrhythmia in patients with chronic unexplained nausea and vomiting", Gastroenterology, 149, pp.56~66.e5 (2015)
19. Farrugia G, "Interstitial cells of Cajal in health and disease", Neurogastroenterol Motil, 20(Suppl 1), pp.54~63 (2008)
20. Grover M, "Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium", Neurogastroenterol Motil, 24, pp.531~539.e249 (2012)
21. Vittal H, "Mechanisms of disease: the pathological basis of gastroparesis: a review of experimental and clinical studies", Nat Clin Pract Gastroenterol Hepatol, 4, pp.336~346 (2007)
22. Orihata M, "Inhibition of nitric oxide synthase delays gastric emptying of solid meals", J Pharmacol Exp Ther, 271, pp.660~670 (1994)
23. Plourde V, "Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats", Eur J Pharmacol, 256, pp.125~129 (1994)
24. Takahashi T, "Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats", Gastroenterology, 113, pp.1535~1544 (1997)
25. Wrzos HF, "Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats", Dig Dis Sci, 42, pp.2106~2110 (1997)
26. Sarker S, "T2063 Inflammatory and hematologic disorders are associated with GI symptoms in diabetic gastroparesis", Gastroenterology, 138(5 Supple 1), pp.S-624~ (2010)
27. Harberson J, "Gastric neuromuscular pathology in gastroparesis: analysis of full-thickness antral biopsies", Dig Dis Sci, 55, pp.359~370 (2010)
28. Soota K, "Immunomodulation for treatment of drug and device refractory gastroparesis", Results Immunol, 6, pp.11~14 (2016)
29. Flanagan EP, "Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility", Neurogastroenterol Motil, 26, pp.1285~1297 (2014)
30. Zárate N, "Severe idiopathic gastroparesis due to neuronal and interstitial cells of Cajal degeneration: pathological findings and management", Gut, 52, pp.966~970 (2003)
31. Stocker A, "Autonomic evaluation of patients with gastroparesis and neurostimulation: comparisons of direct", systemic and indirect, Gastroenterology Res, pp.2016, 9[DOI]
32. Qin C, "Gastric electrical stimulation modulates neuronal activity in nucleus tractus solitarii in rats", Auton Neurosci, 119, pp.1~8 (2005)
33. Cutts T, "Twenty-five years of advocacy for patients with gastroparesis: support group therapy and patient reported outcome tool development", BMC Gastroenterol, 16, pp.107~ (2016)
34. Kedar A, "Sa1332 Bloating and abdominal pain symptoms may be important indicators of disease status in patients with severe dyspepsia or gastroparesis", Gastroenterology, 146(5 Supple 1), pp.S-265~ (2014)
35. Abell TL, "Treatment of gastroparesis: a multidisciplinary clinical review", Neurogastroenterol Motil, 18, pp.263~283 (2006)
36. Bouras EP, "Gastric motility disorders: management that optimizes nutritional status", J Clin Gastroenterol, 38, pp.549~557 (2004)
37. Parrish CR, "Nutrition intervention for the patient with gastroparesis: an update", Pract Gastroenterol, 29, pp.29~66 (2005)
38. Sanaka M, "Effect of cigarette smoking on gastric emptying of solids in Japanese smokers: a crossover study using the 13C-octanoic acid breath test", J Gastroenterol, 40, pp.578~582 (2005)
39. Pfeiffer A, "Effect of ethanol and commonly ingested alcoholic beverages on gastric emptying and gastrointestinal transit", Clin Investig, 70, pp.487~491 (1992)
40. Camilleri M, "Appraisal of medium- and long-term treatment of gastroparesis and chronic intestinal dysmotility", Am J Gastroenterol, 89, pp.1769~1774 (1994)
41. Maple JT, "Direct percutaneous endoscopic jejunostomy: outcomes in 307 consecutive attempts", Am J Gastroenterol, 100, pp.2681~2688 (2005)
42. Fontana RJ, "Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review", Am J Gastroenterol, 91, pp.2174~2178 (1996)
43. Parkman HP, "American Gastroenterological Association. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis", Gastroenterology, 127, pp.1592~1622 (2004)
44. Fraser RJ, "Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus", Diabetologia, 33, pp.675~680 (1990)
45. Bytzer P, "GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications", Am J Gastroenterol, 97, pp.604~611 (2002)
46. Schvarcz E, "Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus", Gastroenterology, 113, pp.60~66 (1997)
47. Jones KL, "Blood glucose concentration influences postprandial fullness in IDDM", Diabetes Care, 20, pp.1141~1146 (1997)
48. McCallum RW, "A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis", Diabetes Care, 6, pp.463~467 (1983)
49. Snape WJ Jr, "Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial", Ann Intern Med, 96, pp.444~446 (1982)
50. Sturm A, "Prokinetics in patients with gastroparesis: a systematic analysis", Digestion, 60, pp.422~427 (1999)
51. Ganzini L, "The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders", Arch Intern Med, 153, pp.1469~1475 (1993)
52. Bateman DN, "Extrapyramidal reactions with metoclopramide", Br Med J (Clin Res Ed), 291, pp.930~932 (1985)
53. Soykan I, "Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson’s disease", Mov Disord, 12, pp.952~957 (1997)
54. Patterson D, "A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis", Am J Gastroenterol, 94, pp.1230~1234 (1999)
55. Basque JR, "Efficacy of itopride hydrochloride on gastric emptying in patients with diabetic gastroparesis", Am J Gastroenterol, 100, pp.S325~ (2005)
56. Talley NJ, "Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials", Gut, 57, pp.740~746 (2008)
57. Stevens JE, "Effect of itopride on gastric emptying in longstanding diabetes mellitus", Neurogastroenterol Motil, 20, pp.456~463 (2008)
58. Weber FH Jr, "Erythromycin: a motilin agonist and gastrointestinal prokinetic agent", Am J Gastroenterol, 88, pp.485~490 (1993)
59. Erbas T, "Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis", Diabetes Care, 16, pp.1511~1514 (1993)
60. Richards RD, "The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin", Am J Gastroenterol, 88, pp.203~207 (1993)
61. Janssens J, "Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies", N Engl J Med, 322, pp.1028~1031 (1990)
62. Jean M Larson, "Advantages of Azithromycin Over Erythromycin in Improving the Gastric Emptying Half-Time in Adult Patients With Gastroparesis", Journal of Neurogastroenterology and Motility (JNM), 16(4), pp.407~413 (2010), 대한소화기 기능성질환∙운동학회
63. Potter TG, "Azithromycin for the treatment of gastroparesis", Ann Pharmacother, 47, pp.411~415 (2013)
64. Chini P, "Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility", Scand J Gastroenterol, 47, pp.422~427 (2012)
65. Moshiree B, "Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis", Dig Dis Sci, 55, pp.675~683 (2010)
66. McCallum RW, "Investigative Team. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis: a randomized, multicentre, placebo-controlled study", Aliment Pharmacol Ther, 26, pp.1121~1130 (2007)
67. Takanashi H, "Motilides: a long and winding road: lessons from mitemcinal (GM-611) on diabetic gastroparesis", Regul Pept, 155, pp.18~23 (2009)
68. McCallum RW, "US Investigative Team. Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial", Aliment Pharmacol Ther, 26, pp.107~116 (2007)
69. Fang J, "Effect of mitemcinal fumarate (GM-611) on gastric emptying in patients with idiopathic or diabetic gastroparesis", Gastroenterology, 126(4 Suppl 2), pp.A483~ (2004)
70. Talley NJ, "Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial", Aliment Pharmacol Ther, 14, pp.1653~1661 (2000)
71. Fraser RJ, "Dent J. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis: effects of cisapride", Gut, 35, pp.172~178 (1994)
72. Corinaldesi R, "Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis", Gut, 28, pp.300~305 (1987)
73. Richards RD, "McCallum RW. Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis", Dig Dis Sci, 38, pp.811~816 (1993)
74. Banh HL, "The use of tegaserod in critically ill patients with impaired gastric motility", Clin Pharmacol Ther, 77, pp.583~586 (2005)
75. Crowell MD, "The effects of tegaserod, a 5-HT receptor agonist, on gastric emptying in a murine model of diabetes mellitus", Neurogastroenterol Motil, 17, pp.738~743 (2005)
76. Gralla RJ, "Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting", N Engl J Med, 305, pp.905~909 (1981)
77. Prakash C, "Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants", Am J Gastroenterol, 94, pp.2855~2860 (1999)
78. Sawhney MS, "Tricyclic antidepressants for chronic vomiting in diabetic patients", Dig Dis Sci, 52, pp.418~424 (2007)
79. Abell TL, "Gastric electrical stimulation in intractable symptomatic gastroparesis", Digestion, 66, pp.204~212 (2002)
80. McCallum RW, "Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years", Clin Gastroenterol Hepatol, 9, pp.314~319.e1 (2011)
81. Cutts TF, "Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?", Neurogastroenterol Motil, 17, pp.35~43 (2005)
82. Sanjeev Singh, "Temporary Endoscopic Stimulation in Gastroparesis-like Syndrome", Journal of Neurogastroenterology and Motility (JNM), 21(4), pp.520~527 (2015), 대한소화기 기능성질환∙운동학회[DOI]
83. Jones MP, "A systematic review of surgical therapy for gastroparesis", Am J Gastroenterol, 98, pp.2122~2129 (2003)
84. Hibbard ML, "Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement", J Gastrointest Surg, 15, pp.1513~1519 (2011)

관련 논문AI추천